DuoNeb
Generic Name:
Ipratropium and Albuterol
Brand Names:
DuoNeb, Combivent
DuoNeb Description:
DuoNeb is a bronchodilator prescribed to prevent air flow blockage and other symptoms associated with lung diseases such as asthma, chronic bronchitis, emphysema, and chronic obstructive pulmonary disease (COPD).
DuoNeb Side Effects:
Treatment with DuoNeb may cause the following side effects:
- Cough
- Headache
- Palpitations
- Itching
- Leg cramps
- Pain
- Voice changes
For more information, visit our DuoNeb side effects page.
DuoNeb Uses:
DuoNeb treats symptoms of coughing, wheezing, difficulty breathing, and chest tightness associated with conditions that affect the lungs and breathing airways. DuoNeb may be prescribed to relieve symptoms of COPD, chronic bronchitis, emphysema, and asthma.
DuoNeb can be inhaled as a powder or liquid through a nebulizer or aerosol canister.
DuoNeb Interactions:
Tell your doctor about all the medications you are taking including over-the-counter medications and health supplements. Ask whether you can take these medications along with DuoNeb.
DuoNeb is not to be used along with phenothiazine antipsychotic and antihistaminic drugs due to an increased risk of cardiac arrhythmias. Some phenothiazine medications include:
- Chlorpromazine
- Fluphenazine
- Fluephenazine decanoate
- Perphenazine
- Prochlorperazine edisylate
- Prochlorperazine maleate
- Prochlorperazine rectal
- Promethazine
- Promethazine rectal
- Thioridazine
- Trifluoperazine
DuoNeb should be avoided if a patient is using linezolid due to an increased risk of adverse cardiovascular effects.
DuoNeb should be avoided if a patient is using sotalol due to an increased risk of causing a bronchospasm and an increased risk of cardiac arrhythmias.
DuoNeb should be used very cautiously with the following medications due to an increased risk of cardiac arrhythmias:
- Anticholinergic agents
- Diuretics
- Beta-receptor blocking agents
- Monoamine oxidase inhibitors
- Beta-adrenergic agents
- Tricyclic antidepressants
Patients with a history or current diagnosis of any of following conditions should consult their doctor before treatment with Doribax:
- Blood circulation problems
- Heart problems
- Heart rhythm problems
- Low blood pressure
- Diabetes
- Difficulty urinating
- Enlarged prostate
- Glaucoma
- Low blood potassium
- Overactive thyroid
- Seizures
- Urinary bladder blockage
DuoNeb Dosage Information:
Typical Dosage Recommendations
Patients should take DuoNeb exactly as prescribed by a doctor, as dosage recommendations differ for the treatment of various conditions.
DuoNeb is distributed as a powder-based and liquid-based inhalable solution intended to be used in an aerosol canister or nebulizer.
Patients are generally prescribed four inhalations a day plus additional inhalations to treat intermittent symptoms of wheezing, chest tightness, and difficulty breathing. Patients should not exceed more than two extra inhalations a day and should not take more than 12 puffs of aerosol in 24 hours.
For aerosol use, breathe in slowly and deeply and press down once on the container to spray DuoNeb into your mouth. Hold your breath for about ten seconds, remove the inhaler, and breathe out slowly. Wait about two minutes in between puffs if prescribed two doses.
For nebulizer use, hold the mask to your mouth, sitting in an upright and comfortable position. Turn on the compressor and breathe normally for the next five to 15 minutes or until mist in the chamber begins to dissipate.
Missing a Dose of DuoNeb
If you miss a dose of DuoNeb, take it as soon as your remember. If it is almost time for your next dose, skip the missed dose and return to your normal dosing schedule. Do not take a double dose to compensate for your missed dose.
DuoNeb Overdose
If you overdose on DuoNeb, seek immediate emergency medical treatment. Patients who overdose on this medication may have a fast heartbeat or chest pain.
DuoNeb FDA Approval:
March 21, 2001
DuoNeb Recall/Black Box Warning Information:
There are no recalls or Black Box warnings for DuoNeb.
-
July 30, 2010, 2:23 pm
-
July 30, 2010, 2:13 pm
-
July 29, 2010, 12:33 pm
-
July 28, 2010, 3:58 pm
